{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:14:01Z","timestamp":1791123241263,"version":"4.1.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1001\/jamaoto.2019.1191","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T15:01:14Z","timestamp":1561042874000},"page":"723","source":"Crossref","is-referenced-by-count":179,"title":["Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to<i>Staphylococcus aureus<\/i>"],"prefix":"10.1001","volume":"145","author":[{"given":"Mian Li","family":"Ooi","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Jane","family":"Drilling","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Morales","sequence":"additional","affiliation":[{"name":"AmpliPhi Australia, Pty Ltd, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fong","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Moraitis","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Macias-Valle","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"},{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Hospital Espa\u00f1ol de M\u00e9xico, Facultad Mexicana de Medicina Universidad La Salle, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Vreugde","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis James","family":"Psaltis","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-John","family":"Wormald","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"ooi190032r1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/lary.21438","article-title":"Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis?","volume":"121","author":"Foreman","year":"2011","journal-title":"Laryngoscope"},{"issue":"6","key":"ooi190032r2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2500\/ajra.2009.23.3413","article-title":"Characterization of bacterial and fungal biofilms in chronic rhinosinusitis.","volume":"23","author":"Foreman","year":"2009","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"ooi190032r3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/alr.22046","article-title":"Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.","volume":"8","author":"Zhang","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"ooi190032r5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature.","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"issue":"3","key":"ooi190032r6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy.","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ooi190032r7","first-page":"267","article-title":"Phage therapy: past history and future prospects.","volume":"47","author":"Carlton","year":"1999","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"ooi190032r8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy.","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"ooi190032r9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/antibiotics3030270","article-title":"Bacteriophages and biofilms.","volume":"3(3)","author":"Harper","year":"2014","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"ooi190032r10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/joim.2012.272.issue-6","article-title":"Biofilm infections, their resilience to therapy and innovative treatment strategies.","volume":"272","author":"R\u00f6mling","year":"2012","journal-title":"J Intern Med"},{"key":"ooi190032r11","doi-asserted-by":"publisher","first-page":"26717","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"ooi190032r12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1473-3099(14)70867-9","article-title":"The phage revolution against antibiotic resistance.","volume":"14(8)","author":"Asavarut","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ooi190032r13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant Staphylococcus aureus infections.","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"ooi190032r14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/alr.2014.4.issue-3","article-title":"Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.","volume":"4","author":"Drilling","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"ooi190032r15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fcimb.2017.00049","article-title":"Long-term safety of topical bacteriophage application to the frontal sinus region.","volume":"7","author":"Drilling","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"ooi190032r16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1128\/AEM.69.1.170-176.2003","article-title":"Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.","volume":"69","author":"Mizoguchi","year":"2003","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"ooi190032r17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo.","volume":"60","author":"Nale","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ooi190032r18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2500\/ajra.2014.28.4001","article-title":"Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.","volume":"28","author":"Drilling","year":"2014","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"ooi190032r19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.anai.2013.06.033","article-title":"Sino-Nasal Outcome Test (SNOT-22): a predictor of postsurgical improvement in patients with chronic sinusitis.","volume":"111","author":"Kennedy","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"ooi190032r20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1365-2273.2000.00349.x","article-title":"Sinus symptom scores: what is the range in healthy individuals?","volume":"25","author":"Walker","year":"2000","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"ooi190032r21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/000348949510410s02","article-title":"Quantification for staging sinusitis.","volume":"167","author":"Lund","year":"1995","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"issue":"12","key":"ooi190032r22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/alr.2017.7.issue-12","article-title":"Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis.","volume":"7","author":"Chowdhury","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"ooi190032r23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12968\/jowc.2009.18.6.42801","article-title":"Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.","volume":"18","author":"Rhoads","year":"2009","journal-title":"J Wound Care"},{"issue":"2","key":"ooi190032r24","first-page":"66","article-title":"Experimental phage therapy of burn wound infection: difficult first steps.","volume":"4","author":"Rose","year":"2014","journal-title":"Int J Burns Trauma"},{"issue":"4","key":"ooi190032r25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/coa.2009.34.issue-4","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa: a preliminary report of efficacy.","volume":"34","author":"Wright","year":"2009","journal-title":"Clin Otolaryngol"},{"issue":"7","key":"ooi190032r26","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ooi190032r27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.virol.2012.09.002","article-title":"Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.","volume":"434","author":"Sarker","year":"2012","journal-title":"Virology"},{"issue":"7","key":"ooi190032r28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1288\/00005537-195607000-00004","article-title":"Staphylococcus bacteriophage lysate aerosol therapy of sinusitis.","volume":"66","author":"Mills","year":"1956","journal-title":"Laryngoscope"},{"issue":"6","key":"ooi190032r29","first-page":"547","article-title":"Bacteriophage therapy of bacterial infections: an update of our institute\u2019s experience.","volume":"48","author":"Weber-Dabrowska","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ooi190032r30","first-page":"934","article-title":"SLPW: a virulent bacteriophage targeting methicillin-resistant Staphylococcus aureus in vitro and in vivo.","volume":"7","author":"Wang","year":"2016","journal-title":"Front Microbiol"},{"issue":"2","key":"ooi190032r31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/AAC.01426-15","article-title":"Antipseudomonal bacteriophage reduces infective burden and inflammatory response in murine lung.","volume":"60","author":"Pabary","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ooi190032r32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.virusres.2007.09.013","article-title":"Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes.","volume":"131","author":"Miedzybrodzki","year":"2008","journal-title":"Virus Res"},{"issue":"3","key":"ooi190032r33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jcp.2005.30.issue-3","article-title":"Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions.","volume":"30","author":"Pound","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"ooi190032r35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh.","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"ooi190032r36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S1473-3099(04)01127-2","article-title":"Therapeutic use of bacteriophages.","volume":"4","author":"Soothill","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"005","key":"ooi190032r37","article-title":"Experimental phage therapy on multiple drug resistant Pseudomonas aeruginosa infection in mice.","volume":"S10","author":"Golkar","year":"2013","journal-title":"J Antivir Antiretrovir"},{"issue":"8","key":"ooi190032r38","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice.","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"pt 12","key":"ooi190032r39","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1099\/jmm.0.2008\/002873-0","article-title":"Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.","volume":"57","author":"Chhibber","year":"2008","journal-title":"J Med Microbiol"},{"issue":"4","key":"ooi190032r40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/AAC.47.4.1301-1307.2003","article-title":"Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.","volume":"47","author":"Westwater","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ooi190032r4","volume-title":"Bacteriophages, Biology and Applications","author":"Guttman","year":"2004"},{"key":"ooi190032r34","volume-title":"Bacteriophage Therapy in Humans","author":"Sulakvelidze","year":"2005"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/article-pdf\/145\/8\/723\/17782538\/jamaotolaryngology_ooi_2019_oi_190032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T09:45:43Z","timestamp":1663753543000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2735735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2019.1191","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}